10-K Decoder · All companies

Madrigal Pharmaceuticals, Inc.

MDGL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$958M$180M+432%
Operating income−$300M−$498M+39.7%
Net income−$288M−$466M+38.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$431M$287M+50.1%
Operating income$56.0M−$114M
Net income$55.4M−$114M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Madrigal's revenue in FY2025?
$958M in FY2025 (Fiscal year ended Dec 31, 2025), +432% vs $180M a year earlier, per its 10-K filed Feb 2026.
Was Madrigal profitable in FY2025?
No: net income was −$288M and operating income −$300M in FY2025.
What was Madrigal's revenue in Q3 2026?
$431M (+50.1% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.